Lisa Akison is a Senior Lecturer in the School of Biomedical Sciences (SBMS) at the University of Queensland. She has conducted research using rodent models for over 30 years and has been a reproductive biologist since 2005. She completed her PhD (2013) and early Post-doctoral training at the Robinson Institute, University of Adelaide, where she examined the molecular regulation of ovulation and oviductal function. Following her move to UQ in 2015, her research focussed on the developmental origins of health and disease, where she examined developmental programming of various organs and physiological processes. In particular, she has examined the impact of prenatal alcohol exposure, examining impacts on the embryo, fetus and adult offspring. She is also interested in the role that the placenta plays in mediating these effects.
Lisa received training in systematic review and meta-analysis methodology in 2016 and has since published systematic reviews on diverse topics in child and infant health. She now teaches critical appraisal of clinical studies and systematic review methodology to 3rd year biomedical science students, as well as endocrinology, physiology and histology. She has research interests in the Scholarship of Teaching and Learning, and is a current member of the Biomedical Education Research Group at SBMS.
Stephen is an experienced academic who has taught physiology to many (some 40,000) UQ students across science, biomedical science, animal and veterinary sciences, health science, exercise science, human movement and nutrition science, dentistry, pharmacy, speech pathology, physiotherapy, occupational therapy, and medical doctor programs. During his career Stephen has been frequently recognised for his innovative teaching practice and strategic leadership in teaching and learning. Stephen was Director of Teaching and Learning in the School of Biomedical Sciences from 2019 to early 2024, and in 2020 was awarded Academic Leader of the Year in the UQ Faculty of Medicine.
Stephen's expertise is endocrinology. His laboratory examines the hormonal control of growth, metabolism, appetite, and reproduction - unravelling the complexity of how hormones regulate physiological mechanisms in healthy individuals versus dysfunction that occurs in disease states.
Stephen also has a keen interest in metacognition of learning, self-regulation of learning, and lifelong learning. He is currently investigating how students develop capabilities during their undergraduate studies that support their future professional roles.
Dr Tamara Butler is an Aboriginal woman of the Undumbi people from the Sunshine Coast region of Queensland, Australia and a NHMRC Emerging Research Fellow at the University of Queensland. She works withing the First Nations Cancer and Wellbeing Research Program. Her work is focused on women’s cancers with the goal of improving cancer outcomes for Aboriginal and Torres Strait Islander people, families, and communities. Broadly Dr Butler’s research interests also include First Nations research methods and process, co-design, wellbeing, and psychosocial aspects of cancer care.
Dr Cuffe is a systems physiologist focused on understanding the complex changes to maternal physiology that occur during pregnancy and the impact of pregnancy dysfunction of programmed cardiovascular, metabolic and renal disease in offspring. Dr Cuffe has a particular focus on understanding the role of the placenta and its hormones in mediating both maternal and offspring disease. He is most recognised for his research investigating how maternal stress, thyroid dysfunction, hypoxia or altered nutrition affect placental development and program disease in the mother after pregnancy as well as her offspring. Dr Cuffe has an exceptional track record and is excited to take new honours and PhD students into his research laboratory.
Dr Jenny Fung is a senior postdoctoral research fellow and lecturer of pharmacology course at the School of Biomedical Sciences (SBMS), UQ. She is an emerging researcher in the reproductive disease field with experience in molecular biology techniques, genetics, functional genomics, statistical and high-throughput computational skills, ex-vivo and in-vivo models of diseases, as well as industry engagement. In 2013, she was awarded a PhD at UQ and continued post-doctoral research in Professor Grant Montgomery's laboratory at QIMRB and IMB, in the field of genetics and genomics with a focus on functional genomics studies in complex diseases and a special interest in endometriosis. Her research has led to the seminal publication identifying the genetics of gene expression in endometrium and the role of gene regulation underlying endometriosis-related pathogenesis. In 2019, she joined Professor Trent Woodruff’s laboratory at SBMS, UQ to work on immunotherapy development for cancer through funding from Pfizer, where she performed immune cell functional assays and genomics analyses. Dr Fung is in a unique position to perform both the wet and dry lab components of multi-disciplinary research. She is currently co-leading multiple projects, where she is contributing her expertise on genetics and functional genomics on immunology to discover target genes and putative pathways underlying disease progression, with an ultimate goal to develop potential effective drugs for reproductive and brain disorders.
I graduated with Honours in Medicine from the University of the West Indies, Jamaica, in 1992. In 1997 I relocated to the UK where I specialised in Obstetrics & Gynaecology and was admitted as a Member of the Royal College of Obstetricians & Gynaecologists in 1999. In 2012 I gained dual accreditation as a Subspecialist in Reproductive Medicine & Surgery and was admitted to the European Specialist Register. In 2012, I was appointed Senior Lecturer and Consultant in Reproductive Medicine & Surgery at University College London (UCL) and UCL Hospitals where I was the clinical lead for IVF and Recurrent Miscarriage and the scientific lead for Mammalian Oocyte Research within UCL’s Institute for Women’s Health. In January 2014 I relocated to Australia after being recruited to UNSW through the DVCR’s Strategic Priority Funding Scheme. At UNSW I jointly set up and co-directed UNSW’s first oocyte biology research lab. In January 2016, following a competitive global search, I was appointed to the fully endowed Christopher Chen Chair in Reproductive Medicine at UQ where I currently head the Christopher Chen Oocyte Research Laboratory. Since relocating to Australia I have been awarded Fellowship of the Royal Australian NZ College of Obstetricians & Gynaecologists.
In parallel with clinical activity, I have developed an internationally leading research program investigating oocyte maturation and oocyte quality. My Ph.D was awarded in 2009 from the University of Newcastle-upon-Tyne (UK) and received a Dean’s commendation. My thesis investigated the regulation of chromosome segregation in mouse and human oocytes and was funded by a WellBeing of Women Research Training Fellowship. My post-doctoral research was undertaken at UCL funded by a prestigious Wellcome Trust Clinician Scientist Fellowship ($1.2 million). At UCL, I was one of the principal investigators in the cross-faculty Mammalian Oocyte and Embryo Research Laboratory. In my first 2 years in Australia, I have secured NHMRC funding as CIA worth over $1 million.
I have placed leading papers on oocyte regulation in high impact journals such as Science, Developmental Cell, Genes & Development and Nature Cell Biology all of which have been cited by the Faculty of 1000 Experts. I have received numerous prizes and awards including the highly prestigious Medical Research Society Young Investigator Award (first and only award made to the specialty of O&G in the UK) and was the first of the UK Walport Clinical Lecturers in all specialties to attain Clinician Scientist status. I was one of the very few to have delivered the RCOG’s William Blair Bell Memorial Lecture whilst still a clinical trainee.
Associate Professor Lauren Kearney is a registered midwife and nurse and is employed as a Conjoint Associate Professor in Midwifery between the School of Nursing, Midwifery and Social Work, UQ and the Women's and Newborn Services, Royal Brisbane and Women's Hospital. Lauren’s teaching expertise is within the postgraduate and higher degree by research areas. Her research track record is strongly focused upon maternal and child health; specifically, within the domains of evaluation of models of care (relating to the perinatal period and early years), intravenous fluid management and access during labour and birth, facilitators to promote a positive and physiological spontaneous vaginal birth, management of postpartum haemorrhage, and strategies for enabling closeness between mothers and infants in the postpartum period. Lauren has strong industry collaborations. The recipient of several competitive research grants in the maternal and child health area, Lauren is passionate about improving the experience of health care for women and children through translation of high-quality evidence into practice.
Treasure McGuire graduated with a Bachelor of Pharmacy and a Bachelor of Science (Pharmacology) from the University of Queensland UQ). She also completed a Postgraduate Diploma in Clinical Pharmacy and Graduate Certificate in Higher Education at UQ. In 2005, she completed her PhD in the School of Population Health, UQ, entitled Consumer medicines call centres: a medication liaison model of pharmaceutical care.
She has held a sennior conjoint appointment between the School of Pharmacy, UQ and Mater Pharmacy, Mater Health, Brisbane since 1996, and was appointed as a Senior Lecturer in 2006. In her Mater role, she has been Assistant Director of Pharmacy (Practice and Development) over this same time period. At UQ, she coordinates a graduate clinical pharmacy course within the Master of Clinical Pharmacy program. In 2016, this program received a UQ Faculty of Health and Behavioural Sciences Team Award for Programs that Enhance Learning and in 2017 a citation in the University of Queensland Award for Excellence in Teaching and Learning.
Treasure’s research is translational, focussing on patient centred-care and quality use of medicines in the domains of medicines information, evidence-based practice, medication safety, reproductive health, complementary medicines, communicable diseases and interprofessional education. She is a Fellow of the Australian College of Pharmacy and a Fellow of the Pharmaceutical Society of Australia.In recognition of her services to medicines information, she received the Lilly International Fellowship in Hospital Pharmacy and the Bowl of Hygeia of the Pharmaceutical Society of Australia. In 2015, she was the recipient of the Sr Eileen Pollard Medal (Mater Research-UQ) for excellence in incorporating research into clinical care provision.
Professor David McIntyre trained in Endocrinology in Australia and Belgium. He works clinically as Director of Obstetric Medicine at Mater Health Services and is an Emeritus Professor in the Faculty of Medicine (Mater Research). David has published over 250 papers (>25000 citations), primarily in the field of medical complications of pregnancy, with a particular focus on diabetes and obesity. Recent research has examined the effects of diabetes, obesity and hypertension during pregnancy on the health of Mothers and Babies, during pregnancy and with long term follow up. David is a Past Chair of the Australasian Diabetes in Pregnancy Society and the International Association of Diabetes in Pregnancy Study Groups (IADPSG). In 2016, David became the first Australian trained clinician to receive the Norbert Freinkel Award for contributions to diabetes in pregnancy from the American Diabetes Association. In 2019 he was awarded the Jørgen Pedersen Lecture for diabetes in pregnancy by DPSG Europe and the Stream Lead Award Lecture for “Diabetes and Women” by the International Diabetes Federation.
I am a basic science researcher with training in cell biology, genetics and research translation. My research investigates the female reproductive system by focusing on the contribution of individual cells. I aim to understand the influence of genetic architecture, differentiation and maturation on these individual cells and how this contributes to changes in the microenvironment that can contribute to disease initiation and progression.
After the completion of my PhD in 2008 at the University of Queensland, I undertook post-doctoral studies at the University of Bern, Department of Biomedical Research (DBMR), focusing on endometriosis, ovarian and endometrial cancer. I curated patient samples from clinical research trials to investigate inflammatory and metabolic components of reproductive tissue and disease and began developing patient-derived models of the endometrium. I established a relationship between endometriosis lesions, nerves and pain and how this interaction was mediated by inflammation. I further developed patient-derived in vitro models to understand the interaction between inflammation and hormonal response of endometriotic lesions and how this could be utilized to target current and novel treatments. On returning to Australia in 2016 I joined the Genomics of Reproductive Disorders laboratory to integrate genetic background into patient-derived in vitro models. I established the Endometriosis Research Queensland Study (ERQS) in collaboration with the Royal Brisbane and Women’s Hospital (RBWH) and extended in vitro models into complex multi-cellular assembloids (combinations of organoids and surrounding stromal cells).
Professor Montgomery was born in New Zealand, completed PhD studies in Animal Science at Massey University and post-doctoral research in France. In 1987, he co-founded the New Zealand Sheep Genomics Program in the Biochemistry Department at the University of Otago and pioneered the introduction of genome mapping methods in farm animals. He moved to Australia in 1999 and joined the Queensland Institute of Medical Research where he ran a successful genome mapping program for human complex disease. In 2016, he moved to the University of Queensland and holds joint appointments at the Institute for Molecular Bioscience (IMB) and the Queensland Brain Institute (QBI). He is a National Health and Medical Research Council Leadership Fellow and Director of the UQ Genome Innovation Hub. He was elected a Fellow the Society for Reproductive Biology in 2012, Fellow of the Australian Academy of Health and Medical Sciences in 2015, and Honorary Fellow of the Royal Society of New Zealand in 2016. His research focusses on discovery of critical genes and pathways increasing risk for common diseases especially reproductive diseases including endometriosis.
Soumyalekshmi Nair has a degree in Veterinary and Animal Sciences (2009) and a Master of Veterinary Science in Animal Biotechnology (2011) from India. She completed her PhD in 2021 from the Faculty of Medicine, the University of Queensland. In her PhD she investigated the role of extracellular vesicles in gestational diabetes mellitus which involves developing extracellular vesicle -based biomarker for the early screening of pregnant women as well as therapeutic targets for the treatment of women with gestational diabetes. She was awarded the Research Training Scholarship from the University of Queensland and received prestigious awards from the Society of Reproductive Investigation and Australian and New Zealand Society for Extracellular Vesicles. Currently she is a Postdoctoral Research Fellow at the Exosome Biology Lab, UQ Centre for Clinical Research (UQCCR). Her research interest is understanding the molecular mechanism by which extracellular vesicles can regulate the key signalling pathways in diseases such as obesity, diabetes, and ovarian cancer, with a focus on translating this knowledge into clinical utility. She has several key publications in the field including research articles and reviews and presented at major national and international conferences. She is passionate about supporting women in science and enhancing community engagement in Science, Technology, Engineering and Mathematics (STEM).
Associate Professor Rae received her PhD in 2007 in the area of reproductive physiology and has been working in the area of Aboriginal and Torres Strait Islander maternal and infant health and chronic disease since that time. She began as the Group Lead for the Indigenous Health Research group at the Mater Research Institute in a role that bridges the Mater, University of QLD and is actively growing partnerships with the Aboriginal community-controlled health sector in QLD. The importance of maternal health for Indigenous communities has been identified as a critical national research priority by Indigenous communities. Her work has had a multidisciplicinary nature and while always focused on the health of Indigneous Australians she has published in areas including pregnancy and birth outcomes, nutrition, psychosocial health, growth and development during infancy, the use of arts in health education to name a few.She has a particular passion for working in partnership to co-design research projects that support improving health outcomes for Aboriginal and Torres Strait Islanders. Her specific focus has primarily been to develop programs that reduce chronic diseases which afflict Aboriginal people more commonly through early detection and diagnosis, health education, and developing a thorough understanding of risk factors that impact on this community. She has mentored her team of staff and students to co-produce and co-disseminate findings from these programs of work and to build research capacity for all team members including those who identify as Indigenous and for those from rural locations of research studies.
Prior to her role at Mater Research, she was the inaugaral Director of the Gomeroi gaaynggal program (2007-2019), which had two major programs of work 1. ArtsHealth for community engagement, health education and health promotion and 2. A Health research program for understanding the development of chronic disease in the Indigenous community through the Gomeroi gaaynggal cohort. Program 1 was successful in transitioning its funding to local Aboriginal community-controlled sector in Tamworth (2019). Prior to its transition, she led a community focussed ArtsHealth program to improve health knowledge, particularly in the areas of social and emotional wellbeing in the community, with the assistance of a team of beginning Indigenous researchers. Over 100,000 hours of community education were delivered through this program. 2. The Gomeroi gaaynggal cohort work has involved the recruitment and retention of a prospective longitudinal cohort of Indigenous women from pregnancy through until the infants are 10 years of age highlighting her expertise in working with Indigenous families during their antenatal and early childhood years. The importance of maternal health for this population is a critical priority to improving the life-long health of the Indigenous communities of Australia.
My research vision is to raise awareness across our society regarding the potential impacts of prenatal alcohol exposure and the whole-body condition of fetal alcohol spectrum disorder (FASD). First to support the prevention of prenatal alcohol exposure through increased access to reproductive health care and reductions in alcohol use. Second, for those who are already affected, I want to increase the availability of assessment and diagnostic services and ensure that all children, young people, and their families can have access to the supports that they need.
Dr Nicole Warrington is a NHMRC Emerging Leadership Fellow at the University of Queensland Institute for Molecular Bioscience. She has a strong background in statistical genetics and has been actively working towards understanding the genetic determinants of early life growth. Dr Warrington studied a Bachelor of Science at Victoria University in Wellington, New Zealand, majoring in Mathematical Statistics and Psychology. She then completed an honours degree at The University of Western Australia, where she developed a keen interest for genetics, and was subsequently awarded an Australian Postgraduate Award to complete her PhD in statistical genetics and life-course epidemiology. During her PhD she spent time at the University of Toronto to gain experience in statistical modelling methods for longitudinal growth trajectories and conducted the first genome-wide association study of longitudinal growth trajectories over childhood. After completing her PhD, Dr Warrington started at the University of Queensland and focused on using genetics to inform about the relationship between birth weight and cardio-metabolic diseases in later life. She pioneered a new statistical method to partition genetic effects on birth weight into maternal and fetal components, and combined this method with a causal modelling approach, Mendelian randomization. This method was instrumental in demonstrating the relationship between birth weight and adult hypertension is driven by genetic effects, over-turning 30 years of research into the effects of intrauterine programming. More recently, her research focus has broadened to determine whether rapid weight growth across early life, including fetal development, childhood and adolescence, causally increases risk of cardio-metabolic disease and in doing so, hopes to identify optimal times across the life-course where interventions could reduce the incidence of cardio-metabolic diseases.
